BPG致力于知识发现和传播
Articles Published Processes
2024/3/27 13:45:26 | Browse: 20 | 下载: 18
Publication Name |
世界华人消化杂志 |
手稿编号 |
39802 |
手稿来源省、自治区或特别行政区 |
浙江省 |
|
Received |
|
2024-01-04 07:10 |
|
Peer-Review Started |
|
2024-01-10 07:56 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-01-28 07:57 |
|
修回稿 |
|
2024-02-04 03:42 |
|
Second Decision |
|
2024-03-12 05:49 |
|
期刊总编辑接受 |
|
|
|
公司总编辑接受 |
|
2024-03-14 00:26 |
|
预出版 |
|
2024-03-14 00:26 |
|
缴纳版面费 |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
排版 |
|
2024-03-27 01:11 |
|
在线出版 |
|
2024-03-27 13:45 |
ISSN |
1009-3079 (print) and 2219-2859 (online) |
开放获取 |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
版权 |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
网址 |
http://www.wjgnet.com |
专业类型 |
消化内科学 |
手稿栏目类型 |
文献综述 |
文章标题 |
生物制剂与炎症性肠病恶性肿瘤发生风险关系的研究进展
|
手稿来源 |
约稿 |
所有作者列表 |
毛雨晴, 孙少鹏, 吕宾, 范一宏 |
ORCID |
|
基金项目及其编号 |
基金项目名称 |
基金编号 |
浙江省中医药科技计划 |
2019ZA056 |
浙江省中医药科技计划 |
2021ZA057 |
浙江省中医药科技计划 |
2022ZB129 |
浙江省医药卫生科技计划项目 |
2023KY864 |
|
通讯作者 |
范一宏, 研究生, 教授, 主任医师, 310003, 杭州市上城区邮电路54号, 浙江中医药大学附属第一医院消化内科. yhfansjr@163.com |
关键词 |
生物制剂; 恶性肿瘤; 炎症性肠病; 溃疡性结肠炎; 克罗恩病, 抗肿瘤坏死因子 |
核心内容提要 |
炎症性肠病(inflammation bowel disease, IBD)的肿瘤风险与生物制剂之间的关系日益引起业界关注. 本文从IBD的自然肿瘤风险、使用生物制剂后的新发肿瘤风险及复发风险三个角度进行综述, 以期为临床药物决策提供参考. |
出版日期 |
2024-03-27 13:45 |
引文著录 |
毛雨晴, 孙少鹏, 吕宾, 范一宏. 生物制剂与炎症性肠病恶性肿瘤发生风险关系的研究进展. 世界华人消化杂志 2024; 32(3): 221-227 |
URL |
https://www.wjgnet.com/1009-3079/full/v32/i3/221.htm |
DOI |
https://dx.doi.org/10.11569/wcjd.v32.i3.221 |
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345